MR imaging of the brain in patients cured of acute lymphoblastic leukemia - The value of gradient echo imaging

American Journal of Neuroradiology

Volumn 27, Issue 3, 2006, Pages 548-552

  Chan, M S M ^a   Roebuck, D J ^b   Yuen, M P ^a   Li, C K ^a   Chan, Yu Leung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN RADIATION; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; GRADIENT ECHO IMAGING; HUMAN; IMAGE ANALYSIS; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; WHITE MATTER; ACUTE LYMPHOCYTIC LEUKEMIA; BRAIN; CHILD; INTRASPINAL DRUG ADMINISTRATION; METHODOLOGY; PATHOLOGY;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN; CHILD; FEMALE; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; REMISSION INDUCTION;

EID: 33745912502     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Miller RW, Young JL Jr, Novakovic B. Childhood cancer. Cancer 1994;75:395-405
2. Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997;80:2321-32
3. Merrill RM, Capocaccia R, Feuer EJ, et al. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol. 2000;29:197-207
4. Brecher ML, Berger P, Freeman Al, et al. Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis. Cancer 1985;56:2430-33
5. Asato R, Akiyama Y, Ito M, et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992;70:1997-2004
6. Matsumoto K, Takahashi S, Sato A, et al. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy-an MR analysis. Int J Radiat Oncol Biol Phys 1995;32:913-18
7. Laitt RD, Chambers EJ, Goddard PR, et al. Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation. Cancer 1995;76:1846-52
8. Harila-Saari AH, Paakko EL, Vainionpaa LK, et al. A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia. Cancer 1998;83:2608-17
9. Wilson DA, Nitschke R, Bowman ME, et al. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphoblastic leukemia: correlation with neuropsychologic deficiencies. Radiology 1991;180:205-09
10. Chessells JM, Hardisty RM, Richards S. Long survival in childhood lymphoblastic leukaemia. Br J Cancer 1987;55:315-19
11. Forestier E, Johansson B, Gustafsson G, et al. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukemia Cytogenetic Study Group. Br J Haematol. 2000;110:147-53
12. Donadieu J, Hill C. Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review. Br J Haematol 2001;115:34-45
13. Donadieu J, Auclerc MF, Baruchel A, et al. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia Study Group. Br J Haematol 1998;102:729-39
14. Schroeder H, Garwicz S, Kristinsson J, et al. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology. Med Pediatr Oncol 1995;25:372-78
15. Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous system leukemia in children (Children's Cancer Study Group A). Cancer 1970;26:404-09
16. West RJ, Graham-Pole J, Hardisty RM, et al. Factors in pathogenesis of central-nervous-system leukaemia. BMJ 1972;3:311-14
17. Nesbit ME Jr, Sather HN, Robison LL, et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad: a report for Children's Cancer Study Group. Lancet 1981;1:461-66
18. Eden OB, Lilleyman JS, Richards S, et al. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII: report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood. Br J Haematol 1991;78:187-96
19. Hill JM, Kornblith AB, Jones D, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998;82:208-18
20. Bleyer WA. Central nervous system leukemia. Pediatr Clin North Am 1988;35:789-814
21. Nachman J, Sather HN, Cherlow JM, et al. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. J Clin Oncol 1998;16:920-30
22. Hill FG, Richards S, Gibson B, et al. The UK Medical Research Council Working Party on Childhood Leukaemia: successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br J Haematol 2004;124:33-46
23. Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-18
24. Kamps WA, Bokkerink JP, Mahlen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). Blood 1999;94:1226-36
25. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000;95:3310-22
26. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia. 2000;14:2205-22
27. Humpl T, Bruhl K, Bohl J, et al. Cerebral haemorrhage in long-term survivors of childhood acute lymphoblastic leukemia. Eur J Pediatr 1997;156:367-70
28. Gaensler EHL, Dillon WP, Edwards MSB, et al. Radiation-induced telangiectasia in the brain simulates cryptic vascular malformations at MR imaging. Radiology 1994;193:629-36
29. Pozzati E, Giangaspero F, Marliani F, et al. Occult cerebrovascular malformations after irradiation. Neurosurgery 1996;39:677-84
30. Iuvone L, Mariotti P, Colosimo C, et al. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer 2002;95:2562-70
31. Kingma A, Mooyaart EL, Kamps WA, et al. Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol-Oncol 1993;15:231-38
32. Paakko E, Talvensaari K, Pyhtinen J, et al. Late cranial MRI after cranial irradiation in survivors of childhood cancer. Neuroradiology 1994;36:652-55
33. Paakko E, Vainionpaa L, Pyhtinen J, et al. Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukemia. Neuroradiology. 1996;38:264-68
34. Hertzberg J, Huk WJ, Ueberall MA, et al. CNS late effects after ALL therapy in Childhood. Part I. neuroradiological findings in long-term survivors of childhood ALL: an evaluation of the interferences between morphology and neuropsychological performance. Med Pedatr Oncol 1997;28:387-400
35. Paakko E, Harila-Saari A, Vanionpaa L, et al. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol 2000;35:456-61
36. Koike S, Aida N, Hata M, et al. Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: frequency, latency, and dose relation. Radiology 2004;230:93-99
37. Chu WC, Chik KW, Chan YL, et al. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy Radiology 2003;229:659-69
38. Kramer JH, Norman D, Brant-Zawadzki, et al. Absence of white matter changes on magnetic resonance imaging in children treated with CNS prophylaxis therapy for leukemia. Cancer 1988;61:928-30
39. Seidel H, Nygaard R, Haave I, Moe PJ. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children. Acta Paediatr 1996;85:450-53
40. Price RA. Histopathology of CNS leukemia and complications of therapy. Am J Pediatr Hematol-Oncol 1979;1:21-30
41. Price RA. Birdwell DA. The central nervous system in childhood leukemia. III. Mineralizing microangiopathy and dystrophic calcification. Cancer 1978;42:717-28
42. Langer T, Martus P, Ottensmeier H, et al. CNS late-effects after ALL therapy in childhood. Part III. Neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 2002:38:320-28
43. Wilkins RH. Natural history of intracranial vascular malformations: a review. Neurosurgery 1985;16:421-30
44. Kim DS, Park YG, Choi JU, et al. An analysis of the natural history of cavernous malformations. Surg Neurol 1997;48:9-17
45. Lien HR, Blomlie V, Saeter G, et al. Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology 1991;179:547-50